Editorials

• The Choice of the Second Graft

  David Glineur

  Rev Esp Cardiol. 2013;66:427-31

• New Drug-eluting Stents: Polymer-free, Biodegradable Polymers or Bioabsorbable Scaffolds?

  Fernando Alfonso

  Rev Esp Cardiol. 2013;66:423-6

• Diabetic Heart Disease and Interventional Cardiology: How Can Clinical Outcomes Be Improved? Revascularization Guided by Hemodynamic Parameters (Fractional Flow Reserve)

  Ashwin Nathan, Laura Mauri

  Rev Esp Cardiol. 2013;66:432-4

• Therapeutic Hypothermia in Cardiac Arrest

  Kjetil Sunde

  Rev Esp Cardiol. 2013;66:346-9

• Minimizing Risk in the Cardiac Catheterization Laboratory

  Ander Regueiro, Susanna Price, Elizabeth J. Haxby

  Rev Esp Cardiol. 2013;66:342-5

• Right and Left Ventricular Diastolic Flow Field: Why Are Measured Intraventricular Pressure Gradients Small?

  Ares Pasipoularides

  Rev Esp Cardiol. 2013;66:337-41

• Outcome in Aortic Stenosis: When the Flow Makes the Difference

  Patrizio Lancellotti, Raluca Dulgheru

  Rev Esp Cardiol. 2013;66:248-50

• Low Gradient Severe Aortic Stenosis With Preserved Ejection Fraction: Don’t Forget the Flow!

  Jean G. Dumesnil, Philippe Pibarot

  Rev Esp Cardiol. 2013;66:245-7

• Aspirin Continues to Attract Research and Debate, 115 Years After Its Synthesis

  Carlo Patrono

  Rev Esp Cardiol. 2013;66:251-4

• Formulating Recommendations With GRADE: A Matter of Confidence

  Pablo Alonso-Coello, Ivan Solà, Ignacio Ferreira-González

  Rev Esp Cardiol. 2013;66:163-7

• Mechanoelectric Feedback in the Ischemic Myocardium: An Interplay That Modulates Susceptibility to Fibrillation

  David Calvo, José Jalife

  Rev Esp Cardiol. 2013;66:168-70

• Clinical Need for Evaluation of Ischemia

  Frank E. Rademakers

  Rev Esp Cardiol. 2013;66:161-2

• Defining the Role of Left Atrial Appendage Closure in Atrial Fibrillation

  Felicita Andreotti, Filippo Crea

  Rev Esp Cardiol. 2013;66:79-82

• Dynamic Evaluation of Exercise Limitation and Functional Class in Patients With Hypertrophic Cardiomyopathy

  Maria Teresa Tome Esteban

  Rev Esp Cardiol. 2013;66:83-4

• Comments on the ESC Guidelines on the Management of Valvular Heart Disease (Version 2012). A Report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology

  Coordinators:Ángel M. Alonso Gómez, José Juan Gómez de DiegoSpanish Society of Cardiology Working Group on Clinical Practice Guidelines for the Treatment of Valvular Heart Disease:Joaquín Barba, Gonzalo Barón, Xavier Borrás, Arturo Evangelista, Ángel Luis Fernández González, Rocío García Orta, Juan José Gómez Doblas, Rosana Hernández Antolín, José M. Hernández García, Patricia Mahía, José Ignacio Sáez de IbarraGroup of Expert Reviewers for the Clinical Practice Guidelines for the Treatment of Valvular Heart Disease:Javier Bermejo, José Cuenca Castillo, Miguel Ángel García Fernández, Rafael García Fuster, Javier López, José Eduardo López Haldón, Pilar Tornos, Alberto San Román, Marta Sitges, Isidre Vilacosta, José Luis ZamoranoSpanish Society of Cardiology Clinical Practice Guidelines Committee:Manuel Anguita, Ángel Cequier, Josep Comín, Isabel Diaz-Buschmann, Ignacio Fernández Lozano, Antonio Fernández-Ortiz, Manuel Pan, Fernando Wornerm

  Rev Esp Cardiol. 2013;66:85-9

• Left Atrium as a Dynamic Three-Dimensional Entity: Implications for Echocardiographic Assessment

  Luigi P. Badano, Angelica Nour, Denisa Muraru

  Rev Esp Cardiol. 2013;66:1-4

• Comments on the ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation

  F. Worner, Spanish Society of Cardiology Working Group on the Clinical Practice Guidelines for ST-Elevation Acute Coronary Syndrome, Group of Expert Reviewers for the Clinical Practice Guidelines for ST-Elevation Acute Coronary Syndrome

  Rev Esp Cardiol. 2013;66:5-11

• Antithrombotic Management and Type of Stent in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

  Juan M. Ruiz-Nodar, Francisco Marín, Gregory Y.H. Lip

  Rev Esp Cardiol. 2013;66:12-6

• Prevention of Infective Endocarditis: Between Progress in Scientific Knowledge and the Lack of Randomized Trials

  Carlos Falces, José M. Miró

  Rev Esp Cardiol. 2012;65:1072-4

• Trends in Myocardial Infarction Mortality in Spain and the United States: A Downhill or Uphill Race in the Twenty-first Century?

  Andrew Moran, Michelle C. Odden

  Rev Esp Cardiol. 2012;65:1069-71